InnoCare Pharma Limited (9969.HK)

HKD 6.1

(0.16%)

Revenue Summary of InnoCare Pharma Limited

InnoCare Pharma Limited's latest annual revenue in 2023 was 738.53 Million CNY , up 18.09% from previous year.
InnoCare Pharma Limited's latest quarterly revenue in 2024 Q1 was 165.82 Million CNY , down -17.57% from previous quarter.
InnoCare Pharma Limited reported a annual revenue of 625.4 Million CNY in annual revenue 2022, down -40.04% from previous year.
InnoCare Pharma Limited reported a annual revenue of 1.04 Billion CNY in annual revenue 2021, up 76368.7% from previous year.
InnoCare Pharma Limited reported a quarterly revenue of 253.91 Million CNY for 2024 Q2, up 53.12% from previous quarter.
InnoCare Pharma Limited reported a quarterly revenue of 738.53 Million CNY for 2023 FY, up 18.09% from previous quarter.

Annual Revenue Chart of InnoCare Pharma Limited (2023 - 2017)

Historical Annual Revenue of InnoCare Pharma Limited (2023 - 2017)

Year	Revenue	Revenue Growth
2023	738.53 Million CNY	18.09%
2022	625.4 Million CNY	-40.04%
2021	1.04 Billion CNY	76368.7%
2020	1.36 Million CNY	9.38%
2019	1.24 Million CNY	-22.88%
2018	1.61 Million CNY	1485.29%
2017	102 Thousand CNY	0.0%

Year	Revenue	Revenue Growth
2024 Q1	165.82 Million CNY	-17.57%
2024 Q2	253.91 Million CNY	53.12%
2023 FY	738.53 Million CNY	18.09%
2023 Q4	201.17 Million CNY	25.88%
2023 Q3	159.81 Million CNY	-15.07%
2023 Q1	189.38 Million CNY	3.04%
2023 Q2	188.16 Million CNY	-0.65%
2022 Q4	183.79 Million CNY	-6.06%
2022 Q3	195.65 Million CNY	54.26%
2022 Q2	126.83 Million CNY	6.48%
2022 Q1	119.12 Million CNY	93.37%
2022 FY	625.4 Million CNY	-40.04%
2021 Q1	50.82 Million CNY	16402.76%
2021 Q3	879.77 Million CNY	1630.86%
2021 Q4	61.6 Million CNY	-93.0%
2021 Q2	50.82 Million CNY	0.0%
2021 FY	1.04 Billion CNY	76368.7%
2020 FY	1.36 Million CNY	9.38%
2020 Q1	374 Thousand CNY	-8.33%
2020 Q3	308 Thousand CNY	-17.65%
2020 Q2	374 Thousand CNY	0.0%
2020 Q4	308 Thousand CNY	0.0%
2019 Q3	246 Thousand CNY	-17.03%
2019 Q2	296.5 Thousand CNY	0.0%
2019 Q1	296.5 Thousand CNY	-58.93%
2019 FY	1.24 Million CNY	-22.88%
2019 Q4	408 Thousand CNY	65.85%
2018 Q3	331 Thousand CNY	17.38%
2018 Q4	722 Thousand CNY	118.13%
2018 Q1	282 Thousand CNY	0.0%
2018 Q2	282 Thousand CNY	0.0%
2018 FY	1.61 Million CNY	1485.29%
2017 FY	102 Thousand CNY	0.0%

Peer Revenue Comparison of InnoCare Pharma Limited

Name	Revenue	Revenue Difference
Uni-Bio Science Group Limited	484.71 Million HKD	-52.364%
CK Life Sciences Int'l., (Holdings) Inc.	5.32 Billion HKD	86.125%